Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs LtdfiledCriticalCortecs Ltd
Priority claimed from PCT/GB1995/001501external-prioritypatent/WO1996000082A1/en
Publication of MXPA97000209ApublicationCriticalpatent/MXPA97000209A/en
Publication of MX9700209ApublicationCriticalpatent/MX9700209A/en
Bromelain, a mixture of enzymes derived from the stem of the pineapple, has been found to be a modulator of intracellular signal transduction, in particular a modulator of pathways in which inositol phosphates play a role, and is therefore useful in the treatment of various diseases and conditions which are mediated by these intracellular signal pathways.
MX9700209A1995-06-261995-06-26Medical use of bromelain.
MX9700209A
(en)
Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
The use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
Process for preparation pharmaceutical composition combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders